Cormedix (NASDAQ:CRMD) is gearing up to announce its quarterly earnings on Thursday, 2026-03-05. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Cormedix will report an earnings per share (EPS) of $0.83.
The market awaits Cormedix’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
Last quarter the company missed EPS by $0.00, which was followed by a 1.84% drop in the share price the next day.
Here’s a look at Cormedix’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.57 | 0.19 | 0.25 | 0.14 |
| EPS Actual | 0.57 | 0.28 | 0.30 | 0.22 |
| Price Change % | -1.84 | -4.44 | 4.66 | -2.45 |
Stock Performance
Shares of Cormedix were trading at $6.91 as of March 03. Over the last 52-week period, shares are …